Benzinga - by David Pinsen, Benzinga Contributor.
Stock Gets Slapped After A Double Beat Shares of Lululemon Athletica, Inc. (NASDAQ: LULU) closed down15.8% on Friday, after the company beat on both top and bottom lines after the close yesterday. The company's earnings per share of $5.29 beat by $0.26, and its revenue of $3.21 billion beat by $10 million. Ostensibly, the stock was down because the company released weaker-than-expected guidance for the year, but one of the top retail analysts I follow, Jeff Mackey, felt the market was overreacting when LULU was down about 12% after hours on Thursday.
Lulu's guide isn't as bad as it sounds. "Guiding q1 Rev higer" > "Calling US consumers slow" Says in the Q&A that the US is "a little soft" compared to Canada(!) and the rest of the world. Conversion down slightly cc @ericjackson pic.twitter.com/x3xoVNs7NrChartmill gives the company a good (7 out of 10) overall fundamental rating, and even higher ratings for profitability (9), growth (8), and health (9). Lululemon also has a Piotroski F-Score of 8 (out of 9) indicating financial strength and lack of dilution.— Jeff Macke (@JeffMacke) March 21, 2024
Taking Advantage Of The Drop With all that in mind, Lululemon looks like a buy here. If it just recoups some of its Friday losses between now and its next earnings report, you could could be up 10% or more by then if you buy the stock here. In the Portfolio Armor trading Substack, we placed an options trade that could generate a gain of more than 200% if the stock is up 12% in the next three months. You can read about it here.
If You Want To Stay In Touch
You can scan for optimal hedges for individual securities, find our current top ten names, and create hedged portfolios on our website. You can also follow Portfolio Armor on X here, or become a free subscriber to our trading Substack using the link below (we're using that for our occasional emails now).
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.